European Commission logo
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS

Artificial Cells with Distributed Cores to Decipher Protein Function

Descripción del proyecto

Imitar los sistemas vivos a microescala

Los sistemas vivos como los tejidos, órganos y orgánulos llevan a cabo procesos biológicos específicos dentro de compartimentos para lograr una mayor eficiencia. Poder sintetizar esta compartimentación funcional artificialmente abriría nuevas posibilidades de obtener avances tecnológicos en el ámbito biomédico. El proyecto ACDC, financiado con fondos europeos, aprovechará la tecnología de laboratorio en un chip y la microfluídica a fin de desarrollar una plataforma funcional que pueda programarse y reconfigurarse para aplicaciones medioambientales o teranósticas. La creación de arquitecturas reactivas seguirá la jerarquía de los sistemas vivos y las cápsulas resultantes serán capaces de comunicarse entre ellas como microlaboratorios y llevar a cabo reacciones químicas o bioquímicas.

Objetivo

We envision a future where ‘chemical apps’ on mobile devices produce on demand valuable compounds for health and performance as well as apps for bioagent threat detection and disease. To take concrete and defined steps toward this future vision, we will exploit the miniaturization provided by lab on a chip technology and construct responsive architectures and metabolism based on living cells and tissues. We will build programmable and re-configurable, (bio)chemical processes, with precision, order, and as hierarchical cellular constructs, in the same way as living systems. We will enable microscale, liquid-based, chemical compartmentalisation (cores), and inter-compartmental (core-core) communication, just as one finds in organelles, cells and tissues. ACDC will focus on developing this next generation technology through a detailed workplan that heavily involves the nontrivial tasks of integrating diverse state of the art technologies including microfluidics, microwave resonators, DNA-based supramolecular assembly, in vitro gene expression and the integration of membrane channels into a functional platform. In a future embodiment of this project, artificial cell technology will be used as programmable and reconfigurable matter for specific applications, including theranostics and personalized medicine as well as sensing and actuation in the environments for bioremediation.
As the first steps towards that future vision, we aim to produce an artificial technological construct and process that recapitulates some aspects of living systems on the microscale, and therefore this project will produce exemplars of secondary living technologies concentrating on the wetware class [1] but also a multi-level mathematical framework. We have assembled an international, interdisciplinary team from academia, industry and public engagement. Our outreach and engagement programme will define the impact in both the public and economic sectors with ethical dimensions considered. Further, building upon 55 years of collective start-up enterprise experience, we will explore the translation of new intellectual property generated into commercial advantage and job creation for the European Union.

Convocatoria de propuestas

H2020-FETPROACT-2018-2020

Consulte otros proyectos de esta convocatoria

Convocatoria de subcontratación

H2020-FETPROACT-2018-01

Régimen de financiación

RIA - Research and Innovation action

Coordinador

UNIVERSITA DEGLI STUDI DI TRENTO
Aportación neta de la UEn
€ 1 198 437,50
Dirección
VIA CALEPINA 14
38122 Trento
Italia

Ver en el mapa

Región
Nord-Est Provincia Autonoma di Trento Trento
Tipo de actividad
Higher or Secondary Education Establishments
Enlaces
Coste total
€ 1 198 437,50

Participantes (5)